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We initiated a worldwide collaborative study, including 455 episodes of bacteremia, to elucidate the clinical
patterns of Klebsiella pneumoniae. Historically, community-acquired pneumonia has been consistently
associated with K. pneumoniae. Only four cases of community-acquired bacteremic K. pneumoniae pneu-
monia were seen in the 2-year study period in the United States, Argentina, Europe, or Australia; none
were in alcoholics. In contrast, 53 cases of bacteremic K. pneumoniae pneumonia were observed in South
Africa and Taiwan, where an association with alcoholism persisted (p=0.007). Twenty-five cases of a dis-
tinctive syndrome consisting of K. pneumoniae bacteremia in conjunction with community-acquired liver
abscess, meningitis, or endophthalmitis were observed. A distinctive form of K. pneumoniae infection,
often causing liver abscess, was identified, almost exclusively in Taiwan.
lebsiella pneumoniae is among the most common gram-
negative bacteria encountered by physicians worldwide.
It is a common hospital-acquired pathogen, causing urinary
tract infections, nosocomial pneumonia, and intraabdominal
infections.  K. pneumoniae is also a potential community-
acquired pathogen. In this international collaborative study, we
evaluated geographic differences and trends in three prominent
presentations of community-acquired Klebsiella infection.
First,  K. pneumoniae has been a recognized pulmonary
pathogen since its discovery >100 years ago. The classic clini-
cal presentation is dramatic: toxic presentation with sudden
onset, high fever, and hemoptysis (currant jelly sputum). Chest
radiographic abnormalities such as bulging interlobar fissure
and cavitary abscesses are prominent. However, the incidence
of community-acquired Klebsiella pneumonia has apparently
declined in the United States (1,2). In studies from the 1920s
to the 1960s, K. pneumoniae was considered an important
cause of community-acquired pneumonia (2); however, in the
last decade K. pneumoniae accounted for <1% of cases of
pneumonia requiring hospitalization in North America (3,4). 
Second, a striking clinical finding concerning a new mani-
festation of community-acquired K. pneumoniae infections has
been documented. An unusual invasive presentation of K.
pneumoniae infection, primary bacteremic liver abscess, has
been described by numerous investigators in Asia; >900
patients with Klebsiella liver abscess have been reported from
Taiwan in the last 10 years (5-22). In addition, case reports and
small series from Korea, Singapore, Japan, India, and Thailand
have been published (23-32). The Taiwanese patients with K.
pneumoniae liver abscess have no history of hepatobiliary dis-
ease. Seventy percent of such patients have diabetes mellitus
(5,13,18,19); 11% to 12% of the reported patients with Kleb-
siella liver abscess have other septic metastatic lesions, includ-
ing pulmonary emboli or abscess, brain abscess, pyogenic
meningitis, endophthalmitis, prostatic abscess, osteomyelitis,
septic arthritis, or psoas abscess (5,13,19).
The third striking clinical observation is the preponderance
of K. pneumoniae as a cause of community-acquired bacterial
meningitis in adults in Taiwan, even in the absence of liver
abscess or other sites of infection. The proportion of cases of
culture-proven bacterial meningitis due to K. pneumoniae in
one Taiwanese hospital increased from 8% during 1981 and
1986 to 18% during 1987 to 1995 (33). In contrast, in a recent
large review only 3 (1.2%) of 253 cases of community-
acquired bacterial meningitis from the Massachusetts General
Hospital were due to K. pneumoniae (34).
Given these empiric observations, we established an inter-
national collaboration of researchers from each of the world’s
populated continents. These investigators worked in large ter-
tiary-care hospitals or hospitals serving veterans. One of our
aims was to delineate in a single time period, with a consistent
set of definitions, global differences in the clinical manifesta-
tions of serious K. pneumoniae infections. We also examined
the influence of prior antibiotic use on these differences in K.
pneumoniae infections. 
*National Cheng Kung University Medical College, Taiwan; †Veterans
Administration Medical Center and University of Pittsburgh, Pittsburgh,
Pennsylvania, USA; ‡University of Queensland, Mater Adults Hospital,
Brisbane, Australia; §Statens Serum Institut, Copenhagen, Denmark;
¶South African Institute of Medical Research, Johannesburg, South
Africa; #Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois,
USA; **Sanatorio San Lucas, Buenos Aires, Argentina; ††University
Hospital, Antwerp, Belgium; and ‡‡Marmara University, Istanbul, Tur-
key
KEmerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 161
RESEARCH
Methods
A prospective study of consecutive patients with commu-
nity-acquired K. pneumoniae bacteremia was performed in 12
hospitals.1 The study period was January 1, 1996, to Decem-
ber 31, 1997. Records of patients >16 years of age with posi-
tive blood cultures for K. pneumoniae were reviewed, and a
188-item study form was completed. All items on the form
were objective criteria, allowing standardization among medi-
cal centers. The study was observational in that administration
of antimicrobial agents and other therapeutic management
were controlled by the patient’s physician, not the investiga-
tors.
Community-acquired bacteremia was defined as a positive
blood culture taken on or within 48 hours of admission. Sever-
ity of acute illness at the time of positive blood cultures was
assessed by a previously validated scoring system, based on
mental status, vital signs, need for mechanical ventilation, and
recent cardiac arrest (Pitt bacteremia score) (35). Type of
infection was defined as pneumonia, urinary tract infection,
meningitis, incisional wound infection, other soft tissue infec-
tion, intraabdominal infection, and primary bloodstream infec-
tion, according to Centers for Disease Control and Prevention
definitions (36). In addition, distinctive sites of K. pneumoniae
bacteremia were further defined as liver abscess, meningitis,
or endophthalmitis. Liver abscesses were defined by the coex-
istence of blood cultures positive for K. pneumoniae and evi-
dence of an intrahepatic abscess cavity by ultrasonography or
computed tomography. Meningitis was defined as culture of K.
pneumoniae  from cerebrospinal fluid, and endophthalmitis
was defined as decreased visual acuity, pain, hypyon, or severe
anterior uveitis in a patient concurrently bacteremic with K.
pneumoniae. Death was defined as including deaths from all
causes within 14 days of the date the first positive blood cul-
ture for K. pneumoniae was obtained.
Blood cultures of K. pneumoniae were sent by participat-
ing hospitals on nutrient agar slants to a central study labora-
tory in Pittsburgh, where the identity of each isolate as K.
pneumoniae was confirmed by the Vitek GNI system
(Biomerieux Vitek, Hazelwood, MO). Extended-spectrum
beta-lactamase (ESBL) production was defined phenotypically
by broth dilution as a >3 twofold concentration decrease in
MIC for either cefotaxime or ceftazidime tested in combina-
tion with clavulanic acid compared with the MIC when tested
alone. The protocol was reviewed and approved by Institu-
tional Review Boards according to local requirements. 
All data were entered into a central database (PROPHET
version 5.1; BBN Systems and Technologies Corporation,
Cambridge, MA). Contingency data were analyzed by two-
tailed chi-square or Fisher’s exact tests, and continuous data
were analyzed by Student t test or Mann-Whitney U test.
Results
Two hundred two (44.4%) of 455 episodes of K. pneumo-
niae bacteremia during the study period were community-
acquired cases. The percentage of cases of K. pneumoniae bac-
teremia that were community acquired in each study country
differed strikingly: 96 (68%) of 142 in Taiwan, 25 (43%) of 68
in the United States, 28 (39%) of 71 in Australia, 40 (34%) of
116 in South Africa, 6 (22%) of 27 in Europe, and 7 (17%) of
41 in Argentina. K. pneumoniae bacteremia in Taiwan was sig-
nificantly more likely to be community acquired than was bac-
teremia in the other countries combined (68% vs. 36%,
p=0.0001).
The characteristics of patients with community-acquired
K. pneumoniae bacteremia from Taiwan, South Africa, and the
rest of the world were compared (Table 1). The source of bac-
teremia in community-acquired cases was geographically dis-
tinctive (Table 2). Pneumonia was the most common infection
worldwide, accounting for 57 (28%) of 202 cases. However,
53 (93%) of 57 of all cases of community-acquired K. pneu-
moniae pneumonia occurred in Taiwan and South Africa. 
Antibiotics had been used for >24 hours before admission
in 21 (10%) of 202 patients. Prior antibiotic use was signifi-
cantly lower in Taiwan (4 [4%] of 96 patients) and South
Africa (2 [5%] of 40) than in the other countries (15 [23%] of
1United States: Pittsburgh Veterans Affairs Medical Center, Pittsburgh,
Pennsylvania, and Rush-Presbyterian-St. Luke’s Medical Center, Chi-
cago, Illinois; Taiwan: National Cheng Kung University Medical Col-
lege, Tainan; Australia: Royal Brisbane Hospital, Mater Adults Hospital,
and Greenslopes Private Hospital, all in Brisbane; South Africa: Hill-
brow Hospital and Baragwanath Hospital, both in Johannesburg; Tur-
key: Marmara University Hospital, Istanbul;  Belgium: University
Hospital, Antwerp; and Argentina: San Lucas Hospital and Comunidad
Olivos Hospital, both in Buenos Aires.
Table 1. Clinical characteristics of patients with community-acquired 
Klebsiella pneumoniae bacteremia from Taiwan, South Africa, and 
other countries
Clinical characteristics
Taiwan 
(n=96)
South 
Africa
(n=40)
Other 
countries
(n=66) p valuea
Age (mean, years) 58.8 47.2  59.9 0.014
Female, n (%) 35 (38%) 17 (42%) 24 (36%) NS 
Underlying diseases, n (%)
  Diabetes mellitus 38 (40%) 8 (20%) 19 (29%) 0.06
  Liver disease 33 (34%) 6 (15%) 12 (18%) 0.02
  Alcoholism 12 (12%) 3 (8%) 1 (2%) 0.08
  Malignancy 15 (16%) 3 (8%) 25 (38%) 0.0002
  HIV infection 0 (0%) 7 (18%) 0 (0%) 0.0001
  Chronic renal failure 6 (6%) 2 (5%) 6 (9%) NS
  Organ transplant 0 (0%) 0 (0%) 7 (11%) 0.0006
  Corticosteroid use 5 (5%) 1 (3%) 7 (11%) NS
No underlying 
disease
22 (23%) 21 (52%) 24 (36%) 0.003
Critically illb 30 (31%) 12 (30%) 2 (3%) 0.0001
Death rate at 14 days, 
n (%)
30 (31%) 24 (60%) 8 (12%) 0.0001
ap values refer to differences between the three regions; NS = not significant at p >0.20.
bCritically ill defined as Pitt bacteremia score >4.RESEARCH
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66) (p=0.0003). In four patients, the prior antibiotic was an
oxyimino-containing cephalosporin (two in South Africa, one
in Argentina, and one in Taiwan). 
ESBL production was detected in 7 (3.5%) of 202 commu-
nity-acquired strains compared with 78 (30.8%) of 253 hospi-
tal-acquired strains (p<0.00001). None of the patients with
community-acquired ESBL-producing strains had recently
received an oxyimino-containing cephalosporin. However, of
the seven patients with community-acquired ESBL-producing
K. pneumoniae bacteremia, only one (a patient with pneumo-
nia from Africa) had no recent hospital exposure. The coun-
tries from which community-acquired ESBL-producing K.
pneumoniae isolates were collected included Africa (three iso-
lates), Turkey (two), the United States (one), and Australia
(one). Twenty-five bloodstream isolates were ciprofloxacin
resistant, of which 7 (28%) of 25 were community acquired.
All these seven patients had serious underlying disease and
frequent hospitalizations or nursing home admissions, and
none had received a quinolone in the 14 days before hospital
admission. Five of seven patients with community-acquired,
ciprofloxacin-resistant K. pneumoniae bacteremia were from
Taiwan. 
Community-Acquired Pneumonia
Community-acquired pneumonia due to K. pneumoniae
was significantly associated with alcoholism (p=0.007); 18%
of patients with pneumonia were alcoholics as defined by their
physicians, compared with 4% with other sources of K. pneu-
moniae bacteremia (Table 3). However, no patient with com-
munity-acquired  K. pneumoniae bacteremic pneumonia
outside South Africa or Taiwan was an alcoholic; of these
patients, one was neutropenic, two were nursing home resi-
dents with neurologic impairment (ages 81 and 90), and one
was a Vietnamese immigrant to Australia with no underlying
illness. 
Community-acquired pneumonia due to K. pneumoniae
was significantly associated with HIV infection on univariate
evaluation (p=0.002). Of the seven patients with HIV infection
and K. pneumoniae bacteremia (all from Africa), six had com-
munity-acquired pneumonia. Community-acquired pneumonia
due to K. pneumoniae was not associated with underlying liver
disease, chronic renal failure, receipt of chemotherapy for
malignant disease, or receipt of corticosteroids. 
Multivariate analysis showed that residing in Africa
(p=0.0001) or Taiwan (p=0.0046) and being an alcoholic
(p=0.04) were significantly associated with community-
Table 2. Worldwide differences in the sites of infection associated 
with community-acquired Klebsiella pneumoniae bacteremia
Infection site
Taiwana
(n=96)
South 
Africa 
(n=40)
Other 
countries 
(n=66) p valueb
Pneumonia 28 (29%) 25 (62%) 4 (6%) 0.0001
Liver abscess 17 (18%) 0 1 (2%) 0.0002
Endophthalmitis 1 (1%) 0 0 NS
Meningitis 5 (5%) 2 (5%) 0 0.06
Urinary tract 
infections
14 (15%) 4 (10%) 25 (38%) 0.0003
Acute cholangitis 13 (14%) 0 12 (18%) 0.02
Intravascular 
catheter-related 
infections
0 2 (5%) 11 (17%) 0
Skin and soft 
tissue infections
5 (5%) 1 (3%) 4 (6%) NS
Spontaneous 
bacterial peritonitis
7 (7%) 0 1 (2%) 0.06
Intraabdominal 
abscess
2 (2%) 2 (5%) 2 (3%) NS
Other 1 (1%) 0 2 (3%) NS
No primary site evi-
dent
7 (7%) 5 (12%) 4 (6%) NS
aFour Taiwanese patients had more than one site of infection: pneumonia and liver 
abscess (2), liver abscess and meningitis (1) and pneumonia and endophthalmitis (1). 
One South African patient had both pneumonia and meningitis.
bp values refer to the differences between the three regions; NS = not significant at p 
>0.20.
Table 3. Comparison of the characteristics of patients with commu-
nity-acquired bacteremic pneumonia due to Klebsiella pneumoniae 
and other patients with community-acquired K. pneumoniae bactere-
mia: association between pneumonia and alcoholism and residence 
in South Africa
Characteristic
Bacteremic 
pneumonia 
(n=57)
Bacteremia 
without
pneumonia 
(n=145) p valuea
Resides in South Africa 25 (44%) 15 (10%) <0.001
Age (years) 53.6 58.6 0.07
Serum creatinineb (mg/
dL)
2.1 2.3 0.2
Blood urea nitrogenb 
(mg/dL)
34.8 37.9 NS
Liver function testsb,c
Serum albumin (g/mL) 2.8 3.1 0.05
Serum bilirubin (mg/dL) 2.8 2.9 NS
AST (IU/mL) 174 303 NS
ALT (IU/mL) 115 189 NS
Underlying disease
Diabetes mellitus (%) 12 (21%) 53 (37%) 0.03
Alcoholism (%) 10 (18%) 6 (4%) 0.007
Malignancy (%) 7 (12%) 36 (25%) 0.05
HIV infection (%) 6 (10%) 1 (1%) 0.002
No underlying disease 23 (40%) 44 (30%) NS (0.17)
Critically ill 21 (37%) 23 (16%) 0.001
Death rate at 14 days (%) 31 (54%) 32 (22%) 0.0001
aNS = not significant at p >0.20; AST = aspartate aminotransferase; ALT = alanine ami-
notransferase. 
bLaboratory values are those taken on first visit to a health-care provider; for continu-
ous variables, the figures in the table are mean values. 
cBacteremic patients with liver cirrhosis, acute cholangitis, and liver abscess were 
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acquired K. pneumoniae pneumonia. HIV infection was not
independently associated with pneumonia (p=0.23). The death
rates from community-acquired pneumonia due to K. pneumo-
niae were 54% in Taiwan and 56% in South Africa.
A Distinctive K. pneumoniae Bacteremia Syndrome
Twenty-five patients had a distinctive syndrome of K.
pneumoniae bacteremia, which was defined by the presence of
K. pneumoniae bacteremia in conjunction with liver abscess,
endophthalmitis, or meningitis. Of these patients, 88% (16
with liver abscess, 4 with meningitis, 1 with liver abscess and
meningitis, and 1 with endophthalmitis) were from Taiwan,
compared with 12% from the other countries combined (2 with
meningitis from South Africa and 1 with liver abscess from
Belgium) (p=0.0001). 
Twelve (67%) of 18 patients with liver abscess had diabe-
tes mellitus. On univariate analysis, residing in Taiwan
(p=0.0001) and having diabetes mellitus (p=0.001) were sig-
nificantly associated with community-acquired K. pneumoniae
liver abscess. Patients with liver abscess were more likely to
have renal failure, but this association was not statistically sig-
nificant (p=0.09). There was no association between liver
abscess and gender, age, previous antibiotic use, or presence of
underlying liver disease. Multivariate analysis showed that
residence in Taiwan (p=0.0034), diabetes mellitus (p=0.0058),
and renal failure (p=0.0178) were significantly associated with
the presence of liver abscess.
Patients with any of the distinctive manifestations of K.
pneumoniae (liver abscess, meningitis, or endophthalmitis)
were compared with patients with other community-acquired
infections (Table 4). These complications were significantly
associated with diabetes mellitus (60% vs. 28%, p=0.0015)
and living in Taiwan (88% vs. 42%, p=0.0001). 
Discussion
When pneumonia due to Klebsiella was first described by
Friedlander in 1882, he believed it to be the most common
cause of bacterial pneumonia (37). Although this concept was
soon refuted in favor of pneumococcus, from the 1930s
through the 1960s, 10 to 50 cases of Klebsiella pneumonia were
reported each year by large hospitals in the United States (2).
U.S. textbooks of medicine continue to list K. pneumoniae as an
important cause of community-acquired pneumonia (38,39).
In our prospective study, we found only four cases of com-
munity-acquired K. pneumoniae pneumonia in 2 years in nine
large hospitals from the United States, Australia, Europe, and
Argentina. The hospitals surveyed included an inner-city vet-
erans hospital in the United States and two large inner-city
public hospitals in Australia. These three centers care for large
numbers of indigent and alcoholic patients.
Recently published reports from the United States, Israel,
and Europe support our observations. Neither Vergis et al. (40)
from the United States nor Lieberman et al. (41) from Israel
found a single case of K. pneumoniae pneumonia in large mul-
ticenter studies of community-acquired pneumonia in the
1990s. Nine European studies published since 1990 show that
only 14 (2.3%) of 621 patients admitted with severe commu-
nity-acquired pneumonia requiring intensive-care unit admis-
sion had K. pneumoniae as the presumptive etiologic agent
(42-50). In contrast, K. pneumoniae continues to be associated
with community-acquired pneumonia in Africa and Asia. In
our study, we observed 28 cases in Taiwan and 25 in South
Africa, accounting for 29% and 62% of all cases of commu-
nity-acquired K. pneumoniae bacteremia in Taiwan and South
Africa, respectively (Table 2). Recent studies from Taiwan,
Singapore, and South Africa corroborate these findings. In a
Taiwanese study, K. pneumoniae accounted for 34% of 41
cases of community-acquired bacteremic pneumonia (51). K.
pneumoniae was the cause of 15% of community-acquired
pneumonia requiring intensive-care unit admission in Sin-
gapore (52). K. pneumoniae was found to be the cause of
pneumonia in 32% of African patients with severe commu-
nity-acquired pneumonia requiring intensive-care unit admis-
sion in Johannesburg (53) and 11% of patients requiring
intensive-care unit admission in Cape Town (54). 
In our study, 18% of patients with community-acquired K.
pneumoniae pneumonia were alcoholics (p=0.007) (Table 3).
Table 4. Comparison of the characteristics of patients with distinctive 
infections associated with community-acquired Klebsiella pneumo-
niae bacteremia (liver abscess, meningitis, and endophthalmitis) and 
other patients with community-acquired K. pneumoniae bacteremia: 
association with diabetes mellitus and residence in Taiwan
Characteristic
Liver abscess, 
endophthalmitis 
or meningitis
 (n=25)
Other 
community-
acquired 
bacteremia 
(n=177) p-valuea
Resides in Taiwan 22 (88%) 74 (42%) 0.0001
Age (years) 55.5 57.4 NS
Serum creatinineb (mg/dL) 2.2 2.2 NS
Blood urea nitrogen 
(mg/dL)
35.7 37.2 NS
Underlying disease
Diabetes mellitus (%) 15 (60%) 50 (28%) 0.0015
Chronic renal failure (%) 3 (12%) 11 (6%) NS
Underlying liver
disease (%)
5 (20%) 46 (26%) NS
Chronic hepatitis B virus 
infection
09  ( 5 % ) N S
Hepatitis C virus 
infection (%)
1 (4%) 8 (5%) NS
Alcoholism (%) 2 (8%) 14 (8%) NS
Malignancy (%) 0 43 (24%) 0.006
No underlying disease 6 (24%) 61 (34%) NS
Critically illc 9 (36%) 35 (20%) 0.07
Death rate at 14 days (%) 8 (32%) 54 (31%) NS
aNS = p >0.20. 
bLaboratory values are those taken on first visit to a health-care provider; for continu-
ous variables, the figures in the table are mean values.
cCritically ill defined as Pitt bacteremia score >4.RESEARCH
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Alcoholics in Africa and Asia may have limited access to
health care (perhaps including reduced access to antibiotics)
compared with those in the Americas, Europe, and Australia,
and may have respiratory symptoms later. A weakness of our
study is that we were not able to ascertain the duration of
symptoms before each patient was hospitalized. However, a
recent study of aborigines from rural northern Australia (35%
of whom were alcoholics and most of whom had suboptimal
access to health-care facilities) showed that none of 90 admit-
ted to hospital with community-acquired pneumonia had K.
pneumoniae infection (55). The hypothesis that Klebsiella
pneumonia is related to poor primary health care for alcoholics
may therefore be less plausible. 
Bacteremic K. pneumoniae liver abscess occurred almost
exclusively in patients from Taiwan (Table 2), consistent with
a growing number of reports from Asia describing this distinc-
tive type of infection. K. pneumoniae was the most common
cause of liver abscesses in Taiwan, Singapore, and Korea in
reports from 1990 to 1999 (5,9,24,31,32); similarly, numerous
reports of liver abscess have recently been published from
Hong Kong, Thailand, and Japan (23,25-30). In total, >900
patients with K. pneumoniae liver abscess have been reported
from Asian countries in the last 10 years; in contrast, reports of
only 23 patients with this condition have been published from
regions outside Asia in this same period (56-63).
K. pneumoniae meningitis in adults has also been infre-
quently reported from North America, Europe, and Australia,
in contrast to Taiwan. In our study, five cases of bacteremic K.
pneumoniae meningitis were in Taiwanese patients and two in
African patients (Table 2). Four (57%) of 7 patients with men-
ingitis had prior diabetes mellitus. Meningitis caused by K.
pneumoniae in the United States, Australia, and Europe is
most often hospital acquired and associated with prior neuro-
surgical procedures or instrumentation. However, of 115 cases
of  K. pneumoniae meningitis reported from Taiwan
(33,64,65), 84% were community acquired, and 64% of cases
had concurrent Klebsiella bacteremia. Unlike pyogenic liver
abscess, the clinical course was fulminant, with a death rate of
57% (33,64,65). The death rate from bacteremic K. pneumo-
niae meningitis in our series was 71%.
We found only one patient (an alcoholic from Taiwan) with
K. pneumoniae bacteremia and endophthalmitis. K. pneumo-
niae endophthalmitis is also likely to be far more common in
Asia than elsewhere; >50 cases have been reported in the last
10 years from Asia (6,10,11,19,27,66-70) compared with only
10 from the United States, Europe, and Australia (57,60,62,71-
76). More than 50% of previously reported Asian patients with
K. pneumoniae endophthalmitis have had concurrent liver
abscess (6,10,11,19,27,66-70).
The reason for the geographic preponderance of these
severe manifestations of K. pneumoniae infections in Asia is
unknown. The geographic diversity of Klebsiella infections
possibly results from interaction between bacterial variables,
host variables (for example, defects in host defense caused by
diabetes mellitus or alcoholism), socioeconomic factors, and
possibly genetic susceptibility in different racial groups. We
are studying the phenotypic and genotypic differences in K.
pneumoniae causing different disease manifestations in differ-
ent countries. Because no more than three hospitals from each
country were included in our study, our results may not neces-
sarily be generalizable to hospitals in other regions. In addi-
tion, other countries in the same continent (e.g., other countries
in Asia or eastern Europe) were not studied but may have differ-
ent clinical patterns compared with the study country.
In summary, our results challenge the classic view of seri-
ous Klebsiella infections. In the United States, Europe, Argen-
tina, and Australia, we have observed that hospital-acquired K.
pneumoniae  infections predominate, with community-
acquired bacteremia being caused by urinary tract infection,
vascular catheter infection, and cholangitis. Classic commu-
nity-acquired pneumonia is no longer an important entity in
these regions. In South Africa, pneumonia (especially in alco-
holics) continues to be an important community-acquired
infection. In Taiwan, community-acquired pneumonia persists,
and distinctive infections such as liver abscess, endophthalmi-
tis, and meningitis have emerged as substantial public health
problems. 
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